Erowid
 
 
Plants - Drugs Mind - Spirit Freedom - Law Arts - Culture Library  
References Database

References Search
All References with Titles containing 'King_T' OR with Authors including 'King_T' OR with Abstract including 'King_T' OR with Keywords including 'King_T'


Author Title JournalName Year   D
Click on Column Headers to Re-Sort The Current List
Rinkel M, DeShon HJ, Hyde... Experimental schizophrenia-like symptoms. Amer. J. Psychiatry 1952
Bradley PB The effect of some drugs on the electrical activity of the brain in th... Eeg & clin. Neurophy... 1953
Bradley PB The effect of some drugs on the electrical activity of the brain of th... Eeg & Clin. Neurophy... 1953
Burroughs W Letter From A Master Addict To Dangerous Drugs British Journal of A... 1956
King T O The Antagonism of 5-Hydroxytryptamine Pneumoconstriction Arch. Int. Phmrmac. ... 1957
Brodie BB, Shore PA A concept for a role of serotonin and norepinephrine as chemical media... Ann. N.Y. Acad. Sc. 1957
Clark LD, Bliss EL Psychopharmacological studies of lysergic acid diethylamide (LSD 25) i... Arch. Neurol. Psychi... 1957
Bertino JR, Klee GD, Wein... Cholinesterase, d-lysergic acid diethylamide and 2-brom-lysergic acid ... J. Clin. Psychopath. 1959
Rolo A, Krinsky LW, Goldf... LSD as an Adjunct to Psychotherapy with Alcoholics J.Psychol. 1960
Böszörményi Z Psilocybin and diethyltryptamine: two tryptamine hallucinogens Neuro-Psychopharmaco... 1961
Higginbottam J, Melton B Some new experiences with L.S.D Nursing Mirror 1961
  Dangers of LSD Lancet 1967
Hirschhorn K, Cohen MM Nonpsychic effects of lysergic acid diethylamide Ann. intern. med 1967
Frosch WA, Robbins E, Rob... Motivation for self-administration of LSD Psychiat.Quart. 1967
Eisner, BG Observations on the Psychotherapeutic Use of Ritalin Alone and in Comb... Unpublished 1968
Kurland, Albert A The therapeutic potential of LSD: its adjunctive use in psychotherapy. Med.Trib.med.News (N... 1970
Datta RK, Ghosh JJ Mescaline-induced changes of brain cortex ribosomes Effect of mescalin... Brain Res 1971
Sheehan DVCF A review of the use of LSD for the patient near death Psychiat. Forum 1972
Titus RJ Lysergic acid diethylamide: its effects on human chromosomes and the h... Int. J. Addict 1972
Richards WA, Grof S, Good... LSD-Assisted Psychotherapy and the Human Encounter with Death Journal of Transpers... 1972
Culver CM, King FW Neuropsychological Assessment of Undergraduate Marihuana and LSD Users Arch.gen.Psychiat. 1974
Robinson JT, Chitham RG, ... Chromosome Aberrations and LSD. A Controlled Study in 50 Psychiatric P... Brit J Psychiat 1974
Dahlberg CC Effects of LSD 25 on Psychotherapeutic Communication Psychopharmacol. Bul... 1974
Rao KR, Fingerman M Color Changes Induced by Certain Indole Alkaloids in the Fiddler Crab,... Comp. Biochem. Physi... 1975
Gintzler AR Interactions Among Narcotics, Neurotransmitters, and phosphodiesterase... Dissertation Abstr I... 1975
Lovell RA, Freedman DX Stereospecific Receptor Sites for d-Lysergic Acid Diethylamide in Rat ... Molec. Pharmacol. 1976
Martin WR, Vaupel DB, Slo... The Mode Of Action Of LSD-like Hallucinogens And Their Identification Psychopharmacology o... 1976
Gallager DW, Aghajanian ... Tricyclic Antidepressant Drugs: Attenuation of Excitatory Effects of d... Life Sci. 1977
Jacoby JH, Poulakos JJ The actions of neuroleptic drugs and putative serotonin receptor antag... JPharm.Pharmacol. 1977
Whitaker PM, Seeman P Hallucinogen binding to dopamine/neuroleptic receptors J.Pharm.Pharmacol. 1977
Winter JC LSD-Induced Stimulus Control: A Comparison of SCH12,679, Fenfluramine,... Psychopharmacology 1978
Decker WJ, Brandes WB LSD Misadventure in Middle Age J. Forens. Sci. 1978
Trulson ME, Crisp T Lack of Synergism and Cross Tolerance Between Tactile Stimulus- and LS... Pharmacology Biochem... 1982
Brouwer JN, Glaser D, Har... The sweetness-inducing effect of miraculin; behavioural and neurophysi... J Physiol 1983
Adams LM, Geyer MA Effects of DOM and DMT in a proposed animal model of hallucinogenic ac... Prog Neuropsychophar... 1985
Arnold WN Vincent van Gogh and the Thujone Connection JAMA 1988
Scherer G, von Maltzan C,... Biomonitoring after controlled exposure to environmental tobacco smoke... Exp Pathol 1989
Ruttenber AJ Stalking the elusive designer drugs: Techniques for monitoring new pro... Journal of Addictive... 1991
Schmidt CJ, Taylor VL, Ab... 5-HT2 antagonists stereoselectively prevent the neurotoxicity of 3,4-m... J Pharmacol Exp Ther 1991
Stevens R Just Say Yes: Drugs and Human Consciousness The Alexander Journa... 1991
Yensen R, Dryer D Thirty Years of Psychedelic Research: The Spring Grove Experiment and ... Orenda Institute 1992
Callaway CW, Rempel N, Pe... Serotonin 5-HT1-like receptors mediate hyperactivity in rats induced b... Neuropsychopharmacol... 1992
Johnson M, Mitros K, Ston... Effect of flunarizine and nimodipine on the decrease in tryptophan hyd... J Pharmacol Exp Ther 1992
Maxwell DL, Polkey MI, He... Hyponatraemia and catatonic stupor after taking 'ecstasy' BMJ 1993
Series H, Boeles S, et al Psychiatric complications of 'Ecstasy' use J Psychopharmacol 1994
Siebert DJ Salvia divinorum and salvinorin A: new pharmacologic findings J Ethnopharmacol 1994
Szara S Are Hallucinogens Psychoheuristic? NIDA Research Monogr... 1994
Azorlosa JL, Greenwald MK... Marijuana smoking: effects of varying puff volume and breathhold durat... J Pharmacol Exp Ther 1995
Miller DB, O'Callaghan JP The role of temperature, stress, and other factors in the neurotoxicit... Mol Neurobiol 1995
Shewan D, Dalgarno P Ecstasy and neurodegeneration. ...such as ketamine BMJ 1996
Hirst M, Smith MT, Crouch... Psychoactive Constituents of the Genus Sceletium N.E.Br. andOther Mese... Journal of Ethnopha... 1996
Smith MT, Crouch NR, Geri... Psychoactive constituents of the genus Sceletium N.E.Br. and other Mes... J Ethnopharmacol 1996
Marlette D Did You Do Drugs, Daddy? Esquire Magazine 1996
Halpern JH The Use of Hallucinogens in the Treatment of Addiction Addiction Research 1996
Lyttle T, Goldstein D, Ga... Bufo toads and bufotenine: fact and fiction surrounding an alleged psy... J Psychoactive Drugs 1996
Lyttle T, Goldstein D, Ga... Bufo toads and bufotenine: fact and fiction surrounding an alleged psy... J Psychoactive Drugs 1996
Kombian SB, Zidichouski J... GABAB receptors presynaptically modulate excitatory synaptic transmiss... J Neurophysiol 1996
Granato P, Weill S, Revil... Ecstasy and dementia in a young subject Eur Psychiatry 1997
Narcessian EJ, Yoon HJ False-positive urine drug screen: beware the poppy seed bagel J Pain Symptom Manag... 1997
Matthias P, Tashkin DP, M... Effects of varying marijuana potency on deposition of tar and delta9-T... Pharmacol Biochem Be... 1997
Redfearn PJ, Agrawal N, M... An association between the regular use of 3,4 methylenedioxy-methamphe... Addiction 1998
Gerra G, Zaimovic A, Giuc... Serotonergic function after (+/-)3,4-methylene-dioxymethamphetamine ('... Int Clin Psychopharm... 1998
Farber NB, Hanslick J, Ki... Serotonergic agents that activate 5HT2A receptors prevent NMDA antagon... Neuropsychopharmacol... 1998
Arun P, Chavan BS, Priti ... Oxytocin abuse: a case report Indian J Psychiatry 1998
Shen M, Thayer SA Cannabinoid receptor agonists protect cultured rat hippocampal neurons... Mol Pharmacol 1998
Metzner R Hallucinogenic drugs and plants in psychotherapy and shamanism J Psychoactive Drugs 1998
Hindmarch I, Quinlan PT, ... The effects of black tea and other beverages on aspects of cognition a... Psychopharmacology B... 1998
Pedersen W, Skrondal A Ecstasy and new patterns of drug use: A normal population study. Addiction 1999
Milosevic A, Agrawal N, R... The occurrence of toothwear in users of Ecstasy (3,4-methylenedioxymet... Community Dent Oral ... 1999
Scearce-Levie K, Viswanat... Locomotor response to MDMA is attenuated in knockout mice lacking the ... Psychopharmacology (... 1999
Scearce-Levie K, Chen JP,... 5-HT receptor knockout mice: pharmacological tools or models of psychi... Ann N Y Acad Sci 1999
Rogers A, McCarthy M Drugs and drugs education in the inner city: The views of 12-year-olds... Drugs: Education, Pr... 1999
Grailhe R, Waeber C, Dula... Increased exploratory activity and altered response to LSD in mice lac... Neuron 1999
Dobkin de Rios M, Stachal... The Duboisia genus, Australian aborigines and suggestibility J Psychoactive Drugs 1999
Weinbroum AA, Rudick V, P... The role of dextromethorphan in pain control Can J Anaesth 2000
Borth S, Hänsel W, Rösner... Synthesis of 2,3- and 3,4-methylenedioxyphenylalkylamines and their re... Forensic Sci Int 2000
Escher M, Desmeules J, Gi... Hepatitis associated with Kava, a herbal remedy for anxiety BMJ 2001
Anderson C Water intake probed in death Boulder Daily Camera 2001
Vaiva G, Boss V, Bailly D... An 'Accidental' Acute Psychosis with Ecstasy Use J Psychoactive Drugs 2001
Jansen KL A review of the nonmedical use of ketamine: use, users and consequence... J Psychoactive Drugs 2001
Roth MD, Marques-Magallan... Induction and regulation of the carcinogen-metabolizing enzyme CYP1A1 ... Am J Respir Cell Mol... 2001
Heinälä P, Alho H, Kiianm... Targeted use of naltrexone without prior detoxification in the treatme... J Clin Psychopharmac... 2001
Rajamani K, Leong S, Lave... Prejunctional actions of methylenedioxymethamphetamine in vas deferens... European Journal of ... 2001
Taylor JR, Jentsch D Repeated intermittent administration of psychomotor stimulant drugs al... Bilogical Psychiatry 2001
Solowij N, Stephens RS, R... Cognitive functioning of long-term heavy cannabis users seeking treatm... JAMA 2002
Heffernan TM, Ling J, Sch... Subjective ratings of prospective memory deficits in MDMA (\'ecstasy\'... Hum Psychopharmacol 2002
Lim DK Ketamine associated psychedelic effects and dependence Singapore Med J 2003
Setola V, Hufeisen SJ, Gr... 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") induces fenflurami... Mol Pharmacol 2003
Pritchard MJ Malignant hyperthermia: clinical features and management Nurs Times 2003
Kleiman MAR Costs and Benefits of Immunotherapies or Depot Medications for the Tre... Committee on Immunot... 2003
Easton N, Fry J, O'Shea E... Synthesis, in vitro formation, and behavioural effects of glutathione ... Brain Res 2003
Verheyden SL, Maidment R,... Quitting ecstasy: an investigation of why people stop taking the drug ... J Psychopharmacol 2003
Curran HV, Rees H, Hoare ... Empathy and aggression: two faces of ecstasy? A study of interpretativ... Psychopharmacology (... 2004
Powell SB, Lehmann-Masten... MDMA 'ecstasy' alters hyperactive and perseverative behaviors in dopam... Psychopharmacology (... 2004
Butler GK, Montgomery AM Impulsivity, risk taking and recreational 'ecstasy' (MDMA) use Drug Alcohol Depend 2004
Sotnikova TD, Beaulieu JM... Dopamine-Independent Locomotor Actions of Amphetamines in a Novel Acut... PLoS Biol 2005
Melamede R Cannabis and tobacco smoke are not equally carcinogenic Harm Reduct J 2005
Sklerov J, Levine B, Moor... A fatal intoxication following the ingestion of 5-methoxy-N,N-dimethyl... J Anal Toxicol 2005
Gobbi G, Bambico FR, Mang... Antidepressant-like activity and modulation of brain monoaminergic tra... pnas 2005
Ott J Obviation of opioid withdrawal syndrome by concomitant administration ... J Psychoactive Drugs 2006

Page 1 of 2   /   146 Entries Returned
Pages:     
 1 
2 next